Inogen (INGN) Non-Current Deferred Tax Liability (2017 - 2026)
Inogen's (INGN) quarterly Non-Current Deferred Tax Liability came in at $6.6 million in Q1 2026, down 11.3% year-on-year from $7.4 million in Q1 2025, and down 2.62% on a QoQ basis from $6.7 million in Q4 2025.
Inogen (INGN) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends
Inogen (INGN) has 10 years of Non-Current Deferred Tax Liability data on file, last reported at $6.6 million in Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 11.3% year-over-year to $6.6 million in Q1 2026; TTM through Mar 2026 was $6.6 million, a 11.3% decrease from a year earlier, with the FY2025 full-year figure at $6.7 million, down 2.86% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $6.6 million, down from $6.7 million in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for INGN reached as high as $8.8 million in Q4 2023 and fell as low as $6.6 million in Q1 2026.
- Historically, Non-Current Deferred Tax Liability has averaged $7.8 million across 5 years, with a median of $8.0 million in 2024.
- Across the five-year window, Non-Current Deferred Tax Liability climbed 1.52% in 2023 and fell 21.1% in 2024, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $8.7 million in 2022, then grew by 1.52% to $8.8 million in 2023, then fell by 21.1% to $6.9 million in 2024, then retreated by 2.86% to $6.7 million in 2025, then retreated by 2.62% to $6.6 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $6.6 million in Q1 2026, $6.7 million in Q4 2025, and $7.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.57 Mn |
| Mar 31, 2026 | 6.57 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 7.89 Mn |
| Sep 30, 2025 | 7.89 Mn |
| Jun 30, 2025 | 7.95 Mn |
| Jun 30, 2025 | 7.95 Mn |
| Mar 31, 2025 | 7.41 Mn |
| Mar 31, 2025 | 7.41 Mn |
| Dec 31, 2024 | 6.95 Mn |
| Dec 31, 2024 | 6.95 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 8.07 Mn |
| Jun 30, 2024 | 8.07 Mn |
| Mar 31, 2024 | 8.15 Mn |
| Mar 31, 2024 | 8.15 Mn |
| Dec 31, 2023 | 8.81 Mn |
| Dec 31, 2023 | 8.81 Mn |